SCHEMBL19544023

SCHEMBL19544023

Oc1ccc2ccccc2c1-c1ccc(Br)c2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.53
▸ PTPN22 Q9Y2R2 1/20 0.47
▸ NSD2 O96028 1/20 0.45
▸ OPRM1 P35372 1/20 0.45
▸ OPRD1 P41143 1/20 0.45
▸ HKDC1 Q2TB90 1/20 0.45
▸ HSP90AA1 P07900 4/20 0.45
▸ HSP90AB1 P08238 4/20 0.45
▸ DNMT1 P26358 1/20 0.44
▸ CYP1A2 P05177 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ PAK1 Q13153 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22738263 0.85 IDO1 (0.54) POLBPTPN22NSD2OPRM1OPRD1
SCHEMBL29360295 0.81 NSD2 (0.54) POLBPTPN22NSD2OPRM1OPRD1
SCHEMBL214870 0.81 NSD2 (0.54) POLBPTPN22NSD2OPRM1OPRD1
SCHEMBL28735042 0.81 CYP1A2 (0.41) POLBCYP1A2USP2HSD17B10MEN1
SCHEMBL31410627 0.79 NSD2 (0.53) POLBPTPN22NSD2OPRM1OPRD1
SCHEMBL9060865 0.79 NSD2 (0.53) POLBPTPN22NSD2OPRM1OPRD1
SCHEMBL1840829 0.79 NSD2 (0.53) POLBPTPN22NSD2OPRM1OPRD1
SCHEMBL29492615 0.79 NSD2 (0.53) POLBPTPN22NSD2OPRM1OPRD1
Hydrochloric Acid SCHEMBL31134043 0.79 PTPN22 (0.57) POLBPTPN22NSD2OPRM1OPRD1
SCHEMBL30574280 0.79 PTPN22 (0.63) POLBPTPN22NSD2OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3326998-B1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO LTD (KR) 2020-12-02 — — EP disclosed
US-10797247-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-10-06 — — US disclosed
EP-3326998-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF Duk San Neolux Co., Ltd. (KR) 2018-05-30 — — EP disclosed
US-20180102486-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-04-12 — — US disclosed
US-20180102486-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-04-12 — — US disclosed
WO-2017188676-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2017-11-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10797247-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, ORAI2, TRPV2 POLB 1909/4885PTPN22 941/4885NSD2 2541/4885
US-20180102486-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, TRPV2 POLB 1909/4885PTPN22 941/4885NSD2 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback